Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX9RU1
|
||||
| Drug Name |
N-1-Dimethyl-8-{[1-(phenylcarbonyl)piperidin-4-yl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
|
||||
| Synonyms |
CHEMBL606409
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H27N7O2
|
||||
| Canonical SMILES |
CNC(=O)c1nn(C)c2c1CCc3cnc(NC4CCN(CC4)C(=O)c5ccccc5)nc23
|
||||
| InChI |
InChI=1S/C24H27N7O2/c1-25-22(32)20-18-9-8-16-14-26-24(28-19(16)21(18)30(2)29-20)27-17-10-12-31(13-11-17)23(33)15-6-4-3-5-7-15/h3-7,14,17H,8-13H2,1-2H3,(H,25,32)(H,26,27,28)
|
||||
| InChIKey |
TZBRTWANJDQXNF-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Aurora kinase A | Target Info | [1587926] | ||
| Glycogen synthase kinase-3 | Target Info | [1587926] | |||
| KEGG Pathway | Oocyte meiosis | ||||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| Pathway Interaction Database | Aurora B signaling | ||||
| Signaling by Aurora kinases | |||||
| Integrin-linked kinase signaling | |||||
| PLK1 signaling events | |||||
| Aurora A signalingbetacatenin_deg_pathway:Degradation of beta catenin | |||||
| Canonical Wnt signaling pathway | |||||
| FOXM1 transcription factor network | |||||
| Class I PI3K signaling events mediated by Akt | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.